Salivary biomarkers for detection of systemic diseases

PLoS One. 2013 Apr 24;8(4):e61356. doi: 10.1371/journal.pone.0061356. Print 2013.

Abstract

Background and objective: Analysis of inflammatory biomarkers in saliva could offer an attractive opportunity for the diagnosis of different systemic conditions specifically in epidemiological surveys. The aim of this study was to investigate if certain salivary biomarkers could be used for detection of common systemic diseases.

Materials and methods: A randomly selected sample of 1000 adults living in Skåne, a county in the southern part of Sweden, was invited to participate in a clinical study of oral health. 451 individuals were enrolled in this investigation, 51% women. All participants were asked to fill out a questionnaire, history was taken, a clinical examination was made and stimulated saliva samples were collected. Salivary concentrations of IL-1β, -6, -8, TNF-α, lysozyme, MMP-8 and TIMP-1 were determined using ELISA, IFMA or Luminex assays.

Results: Salivary IL-8 concentration was found to be twice as high in subjects who had experience of tumour diseases. In addition, IL-8 levels were also elevated in patients with bowel disease. MMP-8 levels were elevated in saliva from patients after cardiac surgery or suffering from diabetes, and muscle and joint diseases. The levels of IL-1β, IL-8 and MMP-8, as well as the MMP-8/TIMP-1 ratio were higher in subjects with muscle and joint diseases.

Conclusion: Biomarkers in saliva have the potential to be used for screening purposes in epidemiological studies. The relatively unspecific inflammatory markers used in this study can not be used for diagnosis of specific diseases but can be seen as markers for increased systemic inflammation.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / metabolism*
  • Cytokines / metabolism
  • Epidemiologic Studies
  • Female
  • Humans
  • Inflammation Mediators / metabolism
  • Male
  • Middle Aged
  • Population Surveillance
  • Saliva / metabolism*
  • Sweden / epidemiology
  • Young Adult

Substances

  • Biomarkers
  • Cytokines
  • Inflammation Mediators

Grants and funding

The study was initiated and financially supported by the Regional Board of Dental Public Health in the county of Skåne, Sweden. The study was also supported by the Swedish National Graduate School in Odontological Science, the Department of Dental Medicine, Division of Periodontology, Karolinska Institutet, Stockholm, Sweden, and Academy of Finland and Helsinki University Central Hospital Research Foundation. Timo Sorsa is inventor of US-Patents 5652227, 5866432 and 6143476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.